Dr. Oliwia Zakerska-Banaszak is employed at the Institute since beginning of 2015, but she is linked with it for more than 7 years before through a master thesis and participation in numerous projects. She gained research experience also during many foreign academic internships, for example in the Institute of Human Genetics in Leipzig, Institute of Cancer Research in Vienna and in the Max Delbrueck Center in Berlin. She was a scholarship holder of international PhD projects programme at the NanoBioMedical Centre at the Department of Physics of the Adam Mickiewicz University in Poznan. She finalized her PhD thesis entitled: „High throughput DNA sequencing as a new diagnostic platform for susceptibility analysis of patients to anaesthetics” with honors in the year 2015. As an employee of Function of Nucleic Acids Department at the Institute of Human Genetics Polish Academy of Sciences she carries out research in the field of pharmacogenetics using high-thoughput sequencing technology. Since 2016 she is laboratory diagnostician and a member of Collegium of Laboratory Medicine in Poland.
dr n. roln. Oliwia Zakerska-Banaszak
Publications
Alterations in Gut Microbiota Composition in Patients with Covid-19: A pilot Study of whole Hypervariable 16S rRNA Gene Sequencing.
Mańkowska-Wierzbicka D, Żuraszek J, Wierzbicka A, Gabryel M, Mahadea D, Baturo A, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M, Dobrowolska A
Biomedicines (MDPI), 2023, Jan 27; 11 (2): 367, 16 str; doi: 10.3390/biomedicines11020367IF-4.757 MNiSW-100
Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review.
Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A
Nutrients (MDPI), 2022, 14 (12), 252, 28 str, doi/10.3390/nu14122520IF-5,719 MNiSW-140
Cytotoxicity of thiopurine drugs in patients with inflammatory bowel disease.
Zakerska-Banaszak O, Łykowska-Szuber L, Walczak M, Żuraszek J, Zielińska A, Skrzypczak-Zielińska M
Toxic, 2022, 10 (4), 151, 19 stron, doi/10.3390/toxics1004015IF-4,146 MNiSW-70
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.
Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Scientific Rep, 2021 Jan 25, 11, art No 2166,.13 str., https://doi.org/10.1038/s41598-021-81628-3IF-3,998 MNiSW-140
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?
Walczak M, Łykowska-Szuber M, Plucińska M, Stawczyk-Eder K, Zakerska-Banaszak O, Eder P, Krela-Kaźmierczak I, Michalak M, Żywicki M, Karłowski WM, Szalata M, Dobrowolska A, Słomski R, Skrzypczak-Zielińska M
Front. Pharmacol., 2020 Aug 14, 11, art 1207,12 str| ,https://doi.org/10.3389/fphar.2020.01207IF-4,225 MNiSW-100
The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study
Mańkowska-Wierzbicka D, Stelmach-Mardas M, Gabryel M, Tomczak H, Skrzypczak-Zielińska M, Zakerska-Banaszak O, Sowińska A, Mahadea D, Baturo A, Wolko Ł, Słomski R, Dobrowolska A
Biomedicines, 2020 Aug 3;8 (8):E268. doi: 10.3390/biomedicines8080268IF-4,717 MNiSW-20
Analysis of the tumor necrosi factor superfamily member 11 gene polymorphism with bone mineral density and bone fracture frequency in patients with postmenopausal osteoporosis.
Wawrzyniak A, Skrzypczak-Zielińska M, Krela-Kaźmierczak I, Michalak M, Marszałek D, Marcinkowska M, Zakerska-Banaszak O, Słomski R
Adv Med Sci, 2020, 65 (2): 291-297. doi: 10.1016/j.advms.2020.05.001IF-2,570 MNiSW-100
Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs.
Walczak M, Skrzypczak-Zielińska M, Plucinska M, Zakerska-Banaszak O, Marszałek D, Łykowska-Szuber L, Stawczyk-Eder K, Dobrowolska A, Słomski R;
Pharmacogenomics J., 2019, 19 (4): 358-367, Epub 2018 Oct 8. doi: 10.1038/s41397-018-0058-9.
Pharmacogenetics of cannabinoids.
Hryhorowicz S, Walczak M, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M;
Eur J Drug Metab Pharmacokinet., 2018, 43 (1): 1-12, Epub 2017 May 22.
Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.
Zakerska-Banaszak O, Skrzypczak-Zielińska M, Tamowicz B, Mikstacki A, Walczak M, Prendecki M, Doroszewska J, Pollak A, Lechowicz U, Oldak M, Huminska-Lisowska K, Molinska-Glura M, Szalata M, Słomski R;
Scientific Report, 2017, Nov 13; 7(1):15399. doi: 10.1038/s41598-017-15657-2.
All publications
Awards
dr n. roln. Oliwia Zakerska-Banaszak
dr hab. n. med. i n. o zdr. Marzena Skrzypczak-Zielińska
prof. dr hab. n. med. Ryszard Słomski
Biocodex award
Award in the competition 'Microbiota in health and disease' for funding a research project entitled "Treatment of patients with irritable bowel syndrome (IBS) by means of intestinal microbiota transplantation - evaluation of the therapy and its effect on the change of the intestinal microbiome". Manager dr Marcin Gabryel.
Scholarship
“Scholarship support for PH.D. students specializing in majors strategic for Wielkopolska’s development”, Sub-measure 8.2.2 Human Capital Operational Programme, co-financed by European Union under the European Social Fund; 2013.
